28619-1-AP

antibody from Proteintech Group

Targeting: FANCD2 FA-D2, FACD, FAD, FANCD

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

28619-1-AP

Provider

Proteintech Group

Product name

FANCD2 antibody

Antibody type

Polyclonal

Description

FANCD2 antibody (Cat. #28619-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

USP5-mediated CD73 deubiquitination drives osimertinib resistance via PI3K/AKT and glycolysis activation in LUAD.

Chen R, Han XH, Zhang Z, Han XJ, Xie J
iScience 2026 Mar 20;29(3):114916

---

MLCK inhibition induces synthetic lethality in MYC-driven cancer.

Sun Z, Wu R, Liang X, Shi T, Zhang Y, Pan Z, Zhang W, Luan X
Cancer letters 2025 Aug 10;625:217803

---

Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development.

Luo Y, Niu M, Liu Y, Zhang M, Deng Y, Mu D, Xu J, Hong S
Frontiers in pharmacology 2024;15:1450875

---

Celastrol induces DNA damage and cell death in BCR-ABL T315I-mutant CML by targeting YY1 and HMCES.

Yang F, Zhou H, Luo P, Jia L, Hou M, Huang J, Gao L, Zhang Q, Guan Y, Bao H, Zhang B, Liu L, Zou C, Yang Q, Wang J, Dai L
Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 Nov;134:155937

---

Gene Transfection Efficiency Improvement with Lipid Conjugated Cationic Carbon Dots.

Chen J, Li F, Zhao B, Gu J, Brejcha NM, Bartoli M, Zhang W, Zhou Y, Fu S, Domena JB, Zafar A, Zhang F, Tagliaferro A, Verde F, Zhang F, Zhang Y, Leblanc RM
ACS applied materials & interfaces 2024 May 29;16(21):27087-27101

---

Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis).

Wang Z, Zhang X, Luo Y, Song Y, Xiang C, He Y, Wang K, Yu Y, Wang Z, Peng W, Ding Y, Liu S, Wu C
Cell death & disease 2024 May 29;15(5):375

---

Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors.

Sun L, Liu Y, Guo X, Cui T, Wu C, Tao J, Cheng C, Chu Q, Ji C, Li X, Guo H, Liang S, Zhou H, Zhou S, Ma K, Zhang N, Wang J, Liu Y, Liu L
Nature communications 2024 Jun 18;15(1):5209

---

Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma.

Yang F, Jia L, Zhou HC, Huang JN, Hou MY, Liu FT, Prabhu N, Li ZJ, Yang CB, Zou C, Nordlund P, Wang JG, Dai LY
Acta pharmacologica Sinica 2024 Feb;45(2):391-404

---

The Compromised Fanconi Anemia Pathway in Prelamin A-Expressing Cells Contributes to Replication Stress-Induced Genomic Instability.

Nie P, Zhang C, Wu F, Chen S, Wang L
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Aug;11(30):e2307751

---

C1orf112 teams up with FIGNL1 to facilitate RAD51 filament disassembly and DNA interstrand cross-link repair.

Zhou Z, Yang H, Liang X, Zhou T, Zhang T, Yang Y, Wang J, Wang W
Cell reports 2023 Aug 29;42(8):112907

---

Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma.

Song L, Wu J, Fu H, Wu C, Tong X, Zhang M
Frontiers in pharmacology 2022;13:921963

---

HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway.

Huang Z, Chen Y, Chen R, Zhou B, Wang Y, Hong L, Wang Y, Wang J, Xu X, Huang Z, Chen W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2022 Nov 16;10(1):e2202437

---

Rapid DNA interstrand cross-linking of Pt(IV) compound.

Zhao CL, Qiao X, Liu XM, Song XQ, Zou YH, Li DQ, Yu XW, Bao WG, Xu JY
European journal of pharmacology 2022 Jun 15;925:174985